Octagon Capital Advisors LP Ngm Biopharmaceuticals Inc Transaction History

Octagon Capital Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$17.26 - $22.02 $3.45 Million - $4.4 Million	-200,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $3.12 Million - $3.98 Million	124,773 Added 165.86%	200,000 $5.81 Million
Q4 2020 Feb 16, 2021	BUY	$16.21 - $31.44 $1.22 Million - $2.37 Million	75,227 New	75,227 $2.28 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Octagon Capital Advisors LP with notifications on news.